Tag: immune checkpoint inhibitors in liver cancer

Microwave ablation, one of the most widely used locoregional treatments for liver cancer, may do far more than simply destroy ...

A groundbreaking study from researchers at the University of Hong Kong’s School of Clinical Medicine reveals that Resmetirom, an FDA-approved ...

In recent years, the advent of immune checkpoint inhibitors has revolutionized the therapeutic landscape of hepatocellular carcinoma (HCC), a primary ...

In a groundbreaking study published in BMC Cancer, researchers have made strides in understanding and predicting liver injury induced by ...

A groundbreaking multinational study has shed new light on immune-mediated adverse events (irAEs) associated with the combination therapy of atezolizumab ...